Free Daily Podcast Summary
Pharmaceutical Executive: Daily Summaries Delivered
by Pharmaceutical Executive Podcast
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Yesterday2 min
Pharmaceutical Executive Daily: FDA Approves Tukysa Plus Trastuzumab and Pertuzumab
Caribou Biosciences discontinues its two allogeneic CAR-T programs, Kamal Biswas makes the case for continuous quality management maturity, and FDA approves Pfizer’s Tukysa as a first-line maintenance therapy in HER2-positive breast cancer.
- 2 days ago3 min
Pharmaceutical Executive Daily: What HCP Engagement Actually Looks Like
Shionogi, Gate Bioscience, and Alector post a trio of new deals, Rajul Jain makes the case for social listening as a medical affairs strategic tool, and Doceree's Vijay Adapala argues that HCP engagement is a systems-design problem, not a communications one.
- 2 days ago27 min
AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?
Can artificial intelligence help turn what many believe is clinical development’s biggest variable — and most prevailing bottleneck — into a more predictable process? In this episode of the Pharm Exec podcast, Matt Walz, CEO of Trialbee, a patient recruitment company, joins Mike Christel, group managing editor, MJH Life Sciences, to discuss how AI is enhancing medical screening, clinical workflows, and enrollment planning. The conversation explores the need for clearer regulatory expectations, human oversight, and workforce training — and why predicting enrollment costs and timelines, Walz believes, could offer one of AI’s most consequential opportunities in clinical trials. Walz also shares how Trialbee is deploying AI on both the patient-facing and operational sides of its business and explains how conversational tools are helping teams move from the world of dashboards to more specific answers.
- 3 days ago3 min
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership
Jewel Jones warns that pharma catches patient disengagement too late, CSL and Alentis Therapeutics join Jiangsu Nhwa and Somnivera in a day of new licensing deals, and Corxel's Bo Liang calls GLP-1's leap to bariatric-surgery-level efficacy the biggest surprise in obesity medicine.
- 6 days ago3 min
Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909
Foghorn Therapeutics and Eli Lilly discontinue their SMARCA2 degrader program, Novartis licenses Abogen's autoimmune mRNA therapy while AstraZeneca, Daiichi Sankyo, and Summit Therapeutics team up on a breast cancer combination trial, and Corxel's Bo Liang makes the case for oral GLP-1 therapies.
- 1 weeks ago2 min
Pharmaceutical Executive Daily: FDA Approves Expanded Indication for Camzyos
Regeneron and Sanofi expand their antibody alliance with four new drug candidates, FDA approves Camzyos for adolescents with obstructive hypertrophic cardiomyopathy, and Michael Abrams questions digital health's savings claims to employers.
- 1 weeks ago2 min
Pharmaceutical Executive Daily: Peptide Ruling Stalls
Novo Nordisk data show real-world weight loss after switching to its oral semaglutide pill, FDA's peptide rulemaking stalls while its enforcement arm targets compounded peptide sellers, and Avi Pardo flags a compliance blind spot in field teams' text messages with doctors.
- 1 weeks ago35 min
A Leadership Call to Action for Biotech
In this episode of Leading Edge with Ken Banta, Jeremy Levin, D.Phil, MB BChir, co-founder and executive chairman of Ovid Therapeutics, joins Banta, The Vanguard Network founder and CEO, for a wide-ranging and candid discussion on the challenges confronting the U.S. biotechnology industry and the leadership required to strengthen its future. Drawing from Levin’s book, Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust, the prominent and outspoken biopharma leader argues that biotechnology is facing pressures that extend well beyond the traditional cycles of capital and investment. The conversation with Banta and Pharmaceutical Executive's Mike Christel turns squarely to leadership and the industry's relationship with the public. Levin challenges pharma and biotech executives to communicate more clearly what their organizations contribute to patients and society — but stresses that communication must be backed by meaningful action. "Mission without method is a waste of time,” he asserts. Banta and Levin also explore the responsibility of corporate boards, how executive incentives can shape organizational priorities and whether the traditional emphasis on shareholder value adequately reflects the broader societal obligations of healthcare companies.
Get Pharmaceutical Executive summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Becker’s Healthcare Podcast
Daily 15-minute episodes covering U.S. healthcare news, analysis, and insights from industry leaders.
Pharmacy Podcast Network
A podcast network featuring dozens of shows on pharmacy practice, policy, and innovation, with interviews across clinical and industry specialties.
The BioHub - by Avetix
Conversations with leading biotech experts reveal the strategies and stories driving innovation in the biotechnology industry.
C-Suite Perspectives
A weekly conversation offering data-driven insights on business topics for executives, hosted by The Conference Board’s CEO.
The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
DGTL Voices with Ed Marx
Conversations with leaders and innovators driving digital transformation in healthcare.
Extend Podcast with Darshan Shah, MD
Explores science-backed strategies and expert insights to extend healthspan and optimize longevity through actionable health protocols.
The Engineering Leadership Podcast
Insights and practices from top software engineering leaders to advance leadership skills in the tech industry.
Leading By Example: Executives Making An Impact
Executives share pivotal moments and personal experiences that shaped their leadership and decision-making in real-world business environments.
The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
Bringing Chemistry to Life
Talks with leading chemists about their discoveries, careers, and the science shaping our world.
About Pharmaceutical Executive
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Pharmaceutical Executive in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Pharmaceutical Executive daily summary?
It's a free AI-powered email that summarizes new episodes of Pharmaceutical Executive as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Pharmaceutical Executive podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Pharmaceutical Executive product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Pharmaceutical Executive Podcast.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Pharmaceutical Executive release new episodes?
Pharmaceutical Executive publishes daily. Our AI generates a summary within hours of each new episode.
What topics does Pharmaceutical Executive cover?
Pharmaceutical Executive covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Pharmaceutical Executive summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.